Cargando…
Tissue and exosomal miRNA editing in Non-Small Cell Lung Cancer
RNA editing in microRNAs has been recently proposed as a novel biomarker in cancer. Here, we investigated RNA editing by leveraging small-RNA sequencing data from 87 NSCLC (Non-Small Cell Lung Cancer) samples paired with normal lung tissues from The Cancer Genome Atlas (TCGA) combined with 26 plasma...
Autores principales: | Nigita, Giovanni, Distefano, Rosario, Veneziano, Dario, Romano, Giulia, Rahman, Mohammad, Wang, Kai, Pass, Harvey, Croce, Carlo M., Acunzo, Mario, Nana-Sinkam, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033928/ https://www.ncbi.nlm.nih.gov/pubmed/29976955 http://dx.doi.org/10.1038/s41598-018-28528-1 |
Ejemplares similares
-
Disparities in Lung Cancer: miRNA Isoform Characterization in Lung Adenocarcinoma
por: Distefano, Rosario, et al.
Publicado: (2022) -
The Epitranscriptome in miRNAs: Crosstalk, Detection, and Function in Cancer
por: del Valle-Morales, Daniel, et al.
Publicado: (2022) -
MiR-124a Regulates Extracellular Vesicle Release by Targeting GTPase Rabs in Lung Cancer
por: Romano, Giulia, et al.
Publicado: (2020) -
Non-Coding RNA Editing in Cancer Pathogenesis
por: Romano, Giulia, et al.
Publicado: (2020) -
Detecting and Characterizing A-To-I microRNA Editing in Cancer
por: Marceca, Gioacchino P., et al.
Publicado: (2021)